Fig. 1From: Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patientsDiaphragm of patient selection. NSCLC, non-small cell lung cancer; EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitors; WBRT, whole brain radiation therapyBack to article page